secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neumora Therapeutics, Inc. (NMRA)
CIK:        0001885522
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193125-24-161572
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neumora stockholders elect Gosebruch and Burow as Class I directors, ratify EY as auditor
--------------------------------------------------------------------------------

- Henry O. Gosebruch elected with 88,190,874 votes for, 2,313,739 withheld, and 12,544,469 broker non-votes.
- Kristina Burow elected with 87,022,169 votes for, 3,482,444 withheld, and 12,544,469 broker non-votes.
- Ratification of Ernst & Young as auditor for FY2024: 102,921,992 for, 123,868 against, 3,222 abstentions.
- As of record date April 15, 2024, 159,452,584 shares were outstanding and entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/0001193125-24-161572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1885522/000119312524161572/d788157d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-161572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer